Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Imatinib 100 mg tablets vs GLIVEC 100 mg tablets under fed conditions in healthy Thai volunteers
TCTR20190218005Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of imatinib (2 arms), sponsored by Bio-innova. Primary endpoint: Bioequivalence pharmacokinetic parameters. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
Beyond the preview
Go deeper on TCTR20190218005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190218005.